Upstream Bio, Inc. is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with initial focus on severe respiratory disorders. Its lead product, verekitug, is a monoclonal antibody that targets and inhibits the TSLP receptor, making it the only known TSLP receptor antagonist in clinical development. Verekitug is in Phase 2 trials for severe asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), and chronic obstructive pulmonary disease (COPD). The company reported positive top-line Phase 2 results in CRSwNP (September 2025) and severe asthma (February 2026), and plans to initiate Phase 3 dosing in both indications in Q1 2027 with quarterly at-home administration.
Q2 FY2026 — expected 2026-09-03
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001193125-26-126188 | EDGAR | 111K words |
| 2025-03-12 | 2024-12-31 | 0000950170-25-037621 | EDGAR | 111K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-11-10 | 2026-09-30 | 0001193125-26-454422 | EDGAR | 71K words |
| 2026-08-11 | 2026-06-30 | 0001193125-26-343417 | EDGAR | 70K words |
| 2025-11-05 | 2025-09-30 | 0001193125-25-265713 | EDGAR | 70K words |
| 2025-08-06 | 2025-06-30 | 0000950170-25-103534 | EDGAR | 69K words |
| 2025-05-06 | 2025-03-31 | 0000950170-25-063957 | EDGAR | 67K words |
| 2024-11-07 | 2024-09-30 | 0000950170-24-122793 | EDGAR | 73K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-11-10 | 0001193125-26-454405 | EDGAR | 2K words |
| 2026-09-01 | 0001193125-26-377485 | EDGAR | 2K words |
| 2026-08-11 | 0001193125-26-343407 | EDGAR | 3K words |
| 2026-03-26 | 0001193125-26-126572 | EDGAR | 28K words |
| 2026-03-26 | 0001193125-26-125057 | EDGAR | 3K words |
| 2026-02-11 | 0001193125-26-045649 | EDGAR | 4K words |
| 2026-02-11 | 0001193125-26-045500 | EDGAR | 2K words |
| 2025-11-05 | 0001193125-25-265705 | EDGAR | 3K words |
| 2025-09-02 | 0002022626-25-000005 | EDGAR | 2K words |
| 2025-08-06 | 0000950170-25-103528 | EDGAR | 3K words |
27 total filings indexed. 9 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0002022626 |
| Ticker | UPB |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.upstreambio.com |
| Listed | 2024-10-11 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/UPB (~200 tokens, structured JSON with cryptographic provenance)